title: Effects of lifestyle interventions on inflammatory markers in the metabolic syndrome.
abstract: Metabolic syndrome (MetS) is a clustering of cardiovascular risk factors which places individuals at increased risk for cardiovascular morbidity and mortality. In addition to obesity and insulin resistance, inflammation is emerging as a potential etiologic factor of the syndrome. One hypothesis suggests that obesity contributes to insulin resistance through increased production of adipose-derived inflammatory cytokines. Currently, lifestyle change is the first line of treatment for MetS. Only recently, however, have studies begun exploring the effect of lifestyle interventions on the mediation of inflammation in individuals with MetS. This review summarizes the strongest evidence (i.e. randomized controlled trial data) for a role of lifestyle interventions (diet and/or exercise) on the improvement of inflammatory biomarkers in people with MetS. Of six studies assessed, lifestyle interventions were consistently successful at improving the inflammatory and metabolic profiles. Interestingly, improvements in the inflammatory profile were found to be largely independent of obesity. Data currently suggest that alterations in dietary composition may be the most effective lifestyle change, although there is a need for more research in this area.
authors.affiliation: J. Paul Sticht Center on Aging, Department of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest, University School of Medicine, Winston-Salem, North Carolina 27157, USA. kbeavers@wfubmc.edu
authors.forename: Kristen M
authors.initials: KM
authors.lastname: Beavers
authors.forename: Barbara J
authors.initials: BJ
authors.lastname: Nicklas
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D002097:C-Reactive Protein / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000178:diet therapy / Q000453:epidemiology / Q000628:therapy*; D007958:Leukocyte Count; D024821:Metabolic Syndrome / Q000178:diet therapy / Q000453:epidemiology / Q000628:therapy*; D015995:Prevalence; D040242:Risk Reduction Behavior
chemical_list: D015415:Biomarkers; D016207:Cytokines; D005340:Fibrinogen; D002097:C-Reactive Protein